Shenzhen YHLO Biotech Co., Ltd.

Shanghai Stock Exchange 688575.SS

Shenzhen YHLO Biotech Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 11.48%

Shenzhen YHLO Biotech Co., Ltd. Return on Capital Employed (ROCE) is 11.48% for the year ending December 31, 2023, a -74.11% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Shenzhen YHLO Biotech Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 44.34%, a 200.04% change year over year.
Shenzhen YHLO Biotech Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 14.78%, a -52.63% change year over year.
Shenzhen YHLO Biotech Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 31.19%, a 51.19% change year over year.
Shenzhen YHLO Biotech Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 20.63%, a 81.80% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Shanghai Stock Exchange: 688575.SS

Shenzhen YHLO Biotech Co., Ltd.

CEO	Mr. Yongbo Song
IPO Date	May 17, 2021
Location	China
Headquarters	Building 1
Employees	1,759
Sector	Healthcare
Industries Biotechnology 3D Printing Cleaning Supplies Hardware & Electronics Medical Instruments Pharmaceuticals Plastics Vaccines

Description

Shenzhen YHLO Biotech Co., Ltd. engages in developing, manufacturing, and distributing in-vitro diagnostic instruments and reagents in China. It offers clinical solutions for autoimmune, reproductive health, infectious, and other diseases; CLIA test panels, chemiluminescence immunoassay analyzers, and integration systems for immunoassay; ELISA test panels and immune analyzers; LIA test panels, blot analyzers, and line immunoassays; POCT test panels and immunofluorescence readers; ESR Analyzers; and COVID-19 detection kits. The company also exports its COVID-19 detection kits to various countries, including Germany, France, Italy, Denmark, Sweden, etc. Shenzhen YHLO Biotech Co., Ltd. was founded in 2008 and is headquartered in Shenzhen, China.

Key trends

Past 5 years